CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Truist Raises Price Target on Elevance Health to $475 From $450, Keeps Buy Rating

Positive
AI Analysis

Summary

Truist raised its price target on Elevance Health to $475 from $450 while maintaining a Buy rating.

Importance:2/10
Sentiment:
0.30
price_target_increaseanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on July 14, 2026 11:34 AM

Read Original